A survey has reported quality of life of data from a cohort of hospitalis patients with type 2 diabetes on either oral antidiabetic agents or insulin regimens.
The study used a questionnaire-based instrument – WHOWOL-BREF – to measure quality of life. The participants had at least 5 years duration of diagnosis and had been hospitalised due to some form of acute crisis.
For type 2 diabetics on insulin:
- poor glycaemic control, poor diet and co-morbid diseases were associated with low quality of life.
- frequent attendance of a clinic had a positive association with better quality of life.
For type 2 diabetics on OADs:
- presence of complications, co-morbid diseases, lack of clinical attendance and poor weight control were associated with low quailty of life
- good glycaemic control and place of residence were positively associated with better quality of life.
Readers of this research are advised to consider:
- Was the sampling and recruitment procedure unbiased?
- The sample population was very specific (hospitalised) and therefore the findings may not transfer to a different patient or population.
- The individual domains within which results weresanalysed.
- The spread and patterns of patient experience is as important as the “overall association” reported above.
- The extent to which the study methods addressed patient-important outcomes.
This is an open access publication, with full-text available for free:
Fal AM, Jankowska B et al. Type 2 diabetes quality of life patients treated with insulin and oral hypoglycemic medication. Acta Diabetologica 2011; 48(3): 237-242, DOI: 10.1007/s00592-010-0244-y